Name | (5aR,9aR)-6-propyl-5a,7,8,9,9a,10-hexahydro-5H-pyrido[2,3-g]quinazolin-2-amine,dihydrochloride |
---|---|
Synonyms |
Quinelorane HCl
Quinelorane dihydrochloride LY-163,502 Quinerlorane hydrochloride |
Description | Quinelorane dihydrochloride (LY163502) is a potent dopamine D3/D2 receptor agonist. Quinelorane has the potential for neurological and psychiatric disorders research[1][2]. |
---|---|
Related Catalog | |
Target |
D2 Receptor D3 Receptor |
In Vivo | Quinelorane dihydrochloride (LY163502; 0.003, 0.01 mg/kg; s.c.) reduces GABA efflux, with significant effects with 0.01 but not 0.003 mg/kg in male Wistar rats (300 g)[1]. Quinelorane dihydrochloride (0.032, 0.32, 3.2, 5.6 mg/kg; IP) significantly and dose-dependently increases locomotor activity in the Sprague Dawley rats. There was no main effect of sex and sex interaction[1]. Quinelorane dihydrochloride significantly decreases activity in the male and female inbred FVB/NJ, BALB/cJ, BALB/cByJ, C57BL/6J, Swiss Webster, A/J, DBA/2J, 129S1/SvImJ, and 129S6/SvEvTac mice[1]. |
References |
Boiling Point | 438.5ºC at 760 mmHg |
---|---|
Molecular Formula | C14H24Cl2N4 |
Molecular Weight | 319.27300 |
Flash Point | 219ºC |
Exact Mass | 318.13800 |
PSA | 55.04000 |
LogP | 3.77110 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |